Our reports suggested that the examination of ULK1 expression, as detected by IHC method, could be used as an effective additional tool to predict the therapeutic response and prognostic outcome of NPC and make the optimal clinical decisions. This evidence concerns the gene ULK1 and nasopharyngeal carcinoma.